Open Medicine, 17 (1), 1869-1882
Metabolic history: Extensive yo-yo dieting history may affect metabolic response, though semaglutide helps many patients whove struggled with previous approaches
This context, interpreted alongside clinical biomarkers and provider assessment, can help clarify whether dual therapy aligns with your metabolic profile and treatment goals
analyzed commercial claims data (see Figure 2) and found that persistent GLP-1 users had $14K-$15K (about 14%) lower average annual total cost of care in the first one to two years of use compared with chronically obese patients who never tried GLP-1s
Blood pressure GLP1R agonists lower BP, particularly in hypertensive individuals, with reductions of 26 mmHg observed in clinical trials
Take control of your health with a medical weight loss consultation for only $50